Form 4: Health Catalyst Director, Duncan Gallagher, Acquires 2,414 Shares of Common Stock

Director Duncan Gallagher acquired 2,414 shares of Health Catalyst, Inc. common stock through a restricted stock unit (RSU) award that vested on September 1, 2024.

Summary

• On September 1, 2024, Duncan Gallagher, a director of Health Catalyst, Inc., acquired 2,414 shares of common stock.
• The acquisition was through the vesting of restricted stock units (RSUs) granted under the company's 2019 Stock Option and Incentive Plan.
• Each RSU represents the right to receive one share of Health Catalyst's common stock.
• 100% of the RSUs vested on September 1, 2024, according to the Issuer's Non-Employee Director Compensation Policy.
• Following the transaction, Gallagher directly owns 76,937 shares of Health Catalyst common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard transaction related to director compensation, indicating alignment of interests between the director and shareholders. There are no explicit negative implications.

Positives

• The vesting of RSUs indicates confidence in the company's future performance from the perspective of the board of directors.
• The director's increased stake in the company aligns his interests with those of other shareholders.

Future Outlook

The document does not contain any specific forward-looking statements.

Industry Context

This type of transaction is common for directors and executives as part of their compensation packages, aligning their interests with the long-term success of the company. It's a standard practice in publicly traded companies to incentivize board members and key employees.

Comparison to Industry Standards

• Director compensation packages often include a mix of salary, stock options, and restricted stock units.
• The vesting schedule and terms of the 2019 Stock Option and Incentive Plan would need to be compared to similar plans at peer companies to assess its competitiveness.
• Companies like Cerner (now Oracle Health), UnitedHealth Group, and McKesson also utilize equity-based compensation for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates